Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI — Stella

Recruiting

Back to Ischemic Stroke trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

China

Nanfang Hospital, Southern Medical University, Guangzhou, Baiyun

Nanfang Hospital,Southern Medical University, Guangzhou, Guangdong

Key details

Sponsor

Nanfang Hospital, Southern Medical University

Enrollment target

~116 participants

Started

April 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov